Abstract
Adverse events/complications are not uncommon with ERCP. Complications include post-ERCP pancreatitis, bleeding, perforation, cardiopulmonary complications, cholecystitis, and others. Diagnostic ERCP should be avoided. Prophylactic pancreatic duct stents reduce risk of post-ERCP pancreatitis of all degrees of severity in high-risk and mixed-risk patients. Rectal indomethacin independently reduces risk of post-ERCP pancreatitis and may have an additive effect to pancreatic stenting. Hemorrhage is largely a function of coagulation status and technique; perforation is almost entirely technique related. Recognition of risk factors and risk modification is key. Any adverse event should be recognized early and endoscopic management is central to management of hemorrhage and perforation. Appropriate supportive and interventional therapy should be initiated to minimize sequelae of complications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335(13):909–18.
Kahaleh M, Freeman M. Prevention and management of post-endoscopic retrograde cholangiopancreatography complications. Clin Endosc. 2012;45(3):305–12.
Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc. 2004;59(7):845–64.
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–11.
Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383–93.
Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol 2009;104(1):31–40.
Artifon EL, Sakai P, Ishioka S, et al. Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial. J Clin Gastroenterol. 2008;42(7):815–9.
Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of ‟covered” versus ‟uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53(5):729–34.
Wilcox CM, Kim H, Ramesh J, Trevino J, Varadarajulu S. Biliary sphincterotomy is not required for bile duct stent placement. Dig Endosc. 2014;26(1):87–92.
Shimizu S, Naitoh I, Nakazawa T, et al. Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction. J Gastroenterol Hepatol. 2013;28(1):68–72.
Cheon YK, Cho KB, Watkins JL, et al. Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification. Gastrointest Endosc. 2007;65(3):385–93.
Johnson GK, Geenen JE, Bedford RA, et al. A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc. 1995;42(4):312–6.
Guda NM, Freeman ML. Are you safe for your patients—how many ERCPs should you be doing? Endoscopy. 2008;40(8):675–76.
Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101(1):139–47.
Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54(4):425–34.
Freeman ML. Pancreatic stents for prevention of post-ERCP pancreatitis: for everyday practice or for experts only? Gastrointest Endosc. 2010;71(6):940–4.
Tse F, Yuan Y, Moayyedi P, Leontiadis GI. Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2013;45(8):605–18.
Freeman ML, Guda NM. ERCP cannulation: a review of reported techniques. Gastrointest Endosc. 2005;61(1):112–25.
Kobayashi G, Fujita N, Imaizumi K, et al. Wire-guided biliary cannulation technique does not reduce the risk of post-ERCP pancreatitis: multicenter randomized controlled trial. Dig Endosc. 2013;25(3):295–302.
Ito K, Fujita N, Noda Y, et al. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial. J Gastroenterol. 2010;45(11):1183–91.
Tarnasky PR. Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications. J Pancreas. 2003;4(1):58–67.
Freeman ML. Pancreatic stents for prevention of post-ERCP pancreatitis: for everyday practice or for experts only? Gastrointest Endosc. 2010;71(6):940–4.
Mazaki T, Mado K, Masuda H, Shiono M. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol. 2014;49(2):343–55.
Sofuni A, Maguchi H, Itoi T, et al. Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol. 2007;5(11):1339–46.
Tsuchiya T, Itoi T, Sofuni A, et al. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: a preliminary, single-center, randomized controlled trial. J Hepatobiliary Pancreat Surg. 2007;14(3):302–7.
Bakman YG, Safdar K, Freeman ML. Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts. Endoscopy. 2009;41(12):1095–98.
Chahal P, Tarnasky PR, Petersen BT, et al. Short 5Fr vs. long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2009;7(8):834–9.
Rashdan A, Fogel EL, McHenry L, Jr, Sherman S, Temkit M, Lehman GA. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol. 2004;2(4):322–9.
Conigliaro R, Manta R, Bertani H, et al. Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trial. Surg Endosc. 2013;27(2):569–74.
Akshintala VS, Hutfless SM, Colantuoni E, et al. Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis. Aliment Pharmacol Ther. 2013;38(11–12):1325–37.
Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366(15):1414–22.
Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc. 2004;59(1):8–14.
Akbar A, Abu Dayyeh BK, Baron TH, Wang Z, Altayar O, Murad MH. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin Gastroenterol Hepatol. 2013;11(7):778–83.
Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48(1):1–10.
Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001;96(2):417–23.
Rabenstein T, Schneider HT, Hahn EG, Ell C. 25 years of endoscopic sphincterotomy in Erlangen: assessment of the experience in 3498 patients. Endoscopy. 1998;30(9):A194–201.
Freeman ML. Adverse outcomes of ERCP. Gastrointest Endosc. 2002;56(6 Suppl):S273–82.
Leung JW, Chan FK, Sung JJ, Chung S. Endoscopic sphincterotomy-induced hemorrhage: a study of risk factors and the role of epinephrine injection. Gastrointest Endosc. 1995;42(6):550–4.
Wilcox CM, Canakis J, Monkemuller KE, Bondora AW, Geels W. Patterns of bleeding after endoscopic sphincterotomy, the subsequent risk of bleeding, and the role of epinephrine injection. Am J Gastroenterol. 2004;99(2):244–8.
Van Os EC, Kamath PS, Gostout CJ, Heit JA. Gastroenterological procedures among patients with disorders of hemostasis: evaluation and management recommendations. Gastrointest Endosc. 1999;50(4):536–43.
Jin YJ, Jeong S, Kim JH, et al. Clinical course and proposed treatment strategy for ERCP-related duodenal perforation: a multicenter analysis. Endoscopy. 2013;45(10):806–12.
Howard TJ, Tan T, Lehman GA, et al. Classification and management of perforations complicating endoscopic sphincterotomy. Surgery. 1999;126(4):658–63.
Machado NO. Management of duodenal perforation post-endoscopic retrograde cholangiopancreatography. When and whom to operate and what factors determine the outcome? A review article. J Pancreas. 2012;13(1):18–25.
Stapfer M, Selby RR, Stain SC, et al. Management of duodenal perforation after endoscopic retrograde cholangiopancreatography and sphincterotomy. Ann Surg. 2000;232(2):191–8.
Freeman ML, Overby C. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents. Gastrointest Endosc. 2003;58(1):41–9.
Banerjee S, Shen B, Baron TH, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008;67(6):791–8.
Epstein L, Hunter JC, Arwady MA, Tsai V, Stein L, Gribogiannis M, Frias M, Guh AY, Laufer AS, Black S, Pacilli M, Moulton-Meissner H, Rasheed JK, Avillan JJ, Kitchel B, Limbago BM, MacCannell D, Lonsway D, Noble-Wang J, Conway J, Conover C, Vernon M, Kallen AJ. New Delhi Metallo-β-Lactamase–Producing Carbapenem-Resistant Escherichia coli Associated With Exposure to Duodenoscopes. JAMA. 2014;312(14):1447-55.
ASGE communication. http://www.informz.net/informzdataservice/onlineversion/ind/bWFpbGluZ2luc3RhbmNlaWQ9MTkwMjY5NCZzdWJzY3JpYmVyaWQ9OTMyNjcxMjU=doi:10.1001/jama.2014.12720.
Garewal D, Powell S, Milan SJ, Nordmeyer J, Waikar P. Sedative techniques for endoscopic retrograde cholangiopancreatography. Cochrane Database Syst Rev. 2012;6:CD007274.
Goudra BG, Singh PM, Sinha AC. Anesthesia for ERCP: impact of anesthesiologist’s experience on outcome and cost. Anesthesiol Res Pract. 2013;2013:570518.
Donepudi S, Chavalitdhamrong D, Pu L, Draganov PV. Air embolism complicating gastrointestinal endoscopy: a systematic review. World J Gastrointest Endosc. 2013;5(8):359–65.
Kapral C, Duller C, Wewalka F, Kerstan E, Vogel W, Schreiber F. Case volume and outcome of endoscopic retrograde cholangiopancreatography: results of a nationwide Austrian benchmarking project. Endoscopy. 2008;40(8):625–30.
Freeman ML, Gupta K. Biliary access techniques for ERCP: from basic to advanced. Instructional DVD #035, American Society for Gastrointestinal Endoscopy, 2007 (63 min). www.asge.org
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic supplementary material
Video Caption
Video 3.1 Placement of prophylactic small caliber pancreatic stent in patient with tiny, tortuous pancreatic duct using 0.018-in. guidewire and 4F 2-cm inner-flanged soft stent
This young woman had recurrent abdominal pain associated with abnormal liver function tests (LFTs) suggestive of sphincter of Oddi dysfunction type II. MRCP showed a normal bile duct but a very tortuous small caliber ventral pancreatic duct. The plan was for ERCP with biliary sphincterotomy and a protective pancreatic stent . This type of pancreatic ductal anatomy leads to virtual impossibility of stent placement using conventional guidewires, as the wire will exit side branches and potentially lead to ductal perforation , while not allowing stability to place a protective stent. Therefore, the case was started with a 5-4-3 cannula (Boston Scientific) loaded with an 0.018″ Roadrunner wire (Cook Medical). The major papilla was very small, adding to technical challenge. The pancreatic duct was cannulated and a very limited amount of contrast injected, which showed the sharp angular turn in the main pancreatic duct. The 0.018″ wire was intentionally knuckled inside the duct, so that the platinum tip would remain intraductal and avoid entering side branches. Normally, we would leave a pancreatic wire and cannulate the bile duct with a second wire. However, the stability of this pancreatic wire was very precarious. As a result, we placed the pancreatic stent before attempting biliary access. With the wire pushed only as far as the first turn, a 4F 2-cm soft material, inner-flanged pancreatic stent (Hobbs Medical) was placed. The inner flange is critical to avoid immediate outward migration. Then, using the guidewire technique, an 0.025-in. wire was used to cannulate bile duct beside the pancreatic stent, and a biliary sphincterotomy performed.
This approach prioritizes early and safe placement of a protective pancreatic stent in a high-risk patient with a very tortuous, small-caliber pancreatic duct in whom conventional guidewire techniques are very risky for ductal perforation or failure to place a pancreatic stent. Additionally, this video demonstrates use of a soft material atraumatic stent to avoid pancreatic ductal injury [32, 53].
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Guda, N., Freeman, M. (2015). Overview of ERCP Complications: Prevention and Management. In: Lee, L. (eds) ERCP and EUS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2320-5_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2320-5_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2319-9
Online ISBN: 978-1-4939-2320-5
eBook Packages: MedicineMedicine (R0)